Concepedia

Vivek Bhaskaran

VB

9

Publications

716

Citations

9

H-Index

2017

Active since

Affiliations

Brigham and Women's Hospital(Current)

Lunenfeld-Tanenbaum Research Institute

University of Toronto

Harvard University

Mount Sinai Hospital

Vivek Bhaskaran is an author at Brigham and Women's Hospital specializing in tumor biology, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2017–2022

9

Publications

9

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition

David Gallo, Jordan T.F. Young, Jimmy Fourtounis et al. · Nature · 2022 · 200 citations · Full text

Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy

Carmela Passaro, Quazim A. Alayo, Isabel DeLaura et al. · Clinical Cancer Research · 2018 · 126 citations · Full text

The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma

Vivek Bhaskaran, Michal O. Nowicki, M. Bennani-Baiti Idriss et al. · Nature Communications · 2019 · 114 citations · Full text

The CIP2A–TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer

Salomé Adam, Silvia Emma Rossi, Nathalie Moatti et al. · Nature Cancer · 2021 · 110 citations

, , +11

Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306

Janek Szychowski, Robert Papp, Evelyne Dietrich et al. · Journal of Medicinal Chemistry · 2022 · 63 citations · Full text

Rows per page

1–5 of 9